Commercio OCGN

Ocugen, Inc.

-

00:00:00

Ocugen, Inc., a clinical-stage biopharmaceutical company, focuses on the developing gene therapies to cure blindness diseases. The company’s pipeline product includes OCU400, a novel gene therapy product candidate restoring retinal integrity and function across a range of genetically diverse inherited retinal diseases, such as retinitis pigmentosa and leber congenital amaurosis; OCU410, gene therapy candidate for the treatment of dry age-related macular degeneration (AMD); and OCU200, a novel fusion protein that is in preclinical development stage for the treatment of diabetic macular edema, diabetic retinopathy, and wet AMD. Ocugen, Inc. has a strategic partnership with CanSino Biologics Inc. for gene therapy co-development and manufacturing; and Bharat Biotech for the commercialization of COVAXIN in the United States market. The company is headquartered in Malvern, Pennsylvania.
Leggi tutto...

OCGN
Specifiche commerciali

Cifre

2

Punto

0.01

Diffusione

floating

Dimensioni del contratto

1

Volume Min

1

Volume massimo

10,000

Volume Step

1

Scambio lungo (punti)

-0.06

Scambio breve (punti)

-0.03
Disponibile su
MT5, TV, cTrader
Ultimo aggiornamento a Dicembre 11, 21:09 GMT+3
*Fonte dei dati: Prezzi del conto MT5 Server Prime

OCGN
Calendario economico

Non sono stati trovati dati

Cambiamento 1D

2.326%

PerchƩ BlackBull Mercati?

26k+

AttivitĆ  negoziabili

1:500

Leva fino a

Regolamentato

Multiregolamentato

24/7

Assistenza clienti

$0

Nessun deposito minimo

Calcolatore del margine

Calculation Results

Current Price

0.87

Required Margin

Converted Currency

Required Margin

Account Base Currency

Calcolatore di profitti e perdite

Calculation Results

PIP Value:

Stop loss in PIPs

Stop loss at :

Take profit in PIPs

Take profit at :

Calcolatore di swap

Calculation Results

0.87

OpportunitĆ  di trading

Non sono stati trovati dati
Join Now